Cargando…
DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy
NLRP3-mediated inflammation is closely related to the pathological progression of diabetic nephropathy (DN). DsbA-L, an antioxidant enzyme, plays a protective role in a variety of diseases by inhibiting ER stress and regulating metabolism. However, the relationship of DsbA-L with inflammation, espec...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120163/ https://www.ncbi.nlm.nih.gov/pubmed/33995126 http://dx.doi.org/10.3389/fphys.2021.659751 |
_version_ | 1783691998523293696 |
---|---|
author | Yang, Ming Luo, Shilu Jiang, Na Wang, Xi Han, Yachun Zhao, Hao Xiong, Xiaofen Liu, Yan Zhao, Chanyue Zhu, Xuejing Sun, Lin |
author_facet | Yang, Ming Luo, Shilu Jiang, Na Wang, Xi Han, Yachun Zhao, Hao Xiong, Xiaofen Liu, Yan Zhao, Chanyue Zhu, Xuejing Sun, Lin |
author_sort | Yang, Ming |
collection | PubMed |
description | NLRP3-mediated inflammation is closely related to the pathological progression of diabetic nephropathy (DN). DsbA-L, an antioxidant enzyme, plays a protective role in a variety of diseases by inhibiting ER stress and regulating metabolism. However, the relationship of DsbA-L with inflammation, especially the NLRP3 inflammasome, has not been examined. In this study, we note that activation of the NLRP3 inflammasome and exacerbated fibrosis were observed in the kidneys of diabetic DsbA-L-knockout mice and were accompanied by decreased phosphorylation of AMP-activated protein kinase (AMPK). Moreover, correlation analysis shows that the phosphorylation of AMPK was negatively correlated with NLRP3 expression and tubular damage. In addition, the decreased AMPK phosphorylation and NLRP3 activation induced by high glucose (HG) in HK-2 cells could be alleviated by the overexpression of DsbA-L. Interestingly, the protective effect of DsbA-L was eliminated after treatment with compound C, a well-known AMPK inhibitor. Our findings suggest that DsbA-L inhibits NLRP3 inflammasome activation by promoting the phosphorylation of AMPK. |
format | Online Article Text |
id | pubmed-8120163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81201632021-05-15 DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy Yang, Ming Luo, Shilu Jiang, Na Wang, Xi Han, Yachun Zhao, Hao Xiong, Xiaofen Liu, Yan Zhao, Chanyue Zhu, Xuejing Sun, Lin Front Physiol Physiology NLRP3-mediated inflammation is closely related to the pathological progression of diabetic nephropathy (DN). DsbA-L, an antioxidant enzyme, plays a protective role in a variety of diseases by inhibiting ER stress and regulating metabolism. However, the relationship of DsbA-L with inflammation, especially the NLRP3 inflammasome, has not been examined. In this study, we note that activation of the NLRP3 inflammasome and exacerbated fibrosis were observed in the kidneys of diabetic DsbA-L-knockout mice and were accompanied by decreased phosphorylation of AMP-activated protein kinase (AMPK). Moreover, correlation analysis shows that the phosphorylation of AMPK was negatively correlated with NLRP3 expression and tubular damage. In addition, the decreased AMPK phosphorylation and NLRP3 activation induced by high glucose (HG) in HK-2 cells could be alleviated by the overexpression of DsbA-L. Interestingly, the protective effect of DsbA-L was eliminated after treatment with compound C, a well-known AMPK inhibitor. Our findings suggest that DsbA-L inhibits NLRP3 inflammasome activation by promoting the phosphorylation of AMPK. Frontiers Media S.A. 2021-04-30 /pmc/articles/PMC8120163/ /pubmed/33995126 http://dx.doi.org/10.3389/fphys.2021.659751 Text en Copyright © 2021 Yang, Luo, Jiang, Wang, Han, Zhao, Xiong, Liu, Zhao, Zhu and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Yang, Ming Luo, Shilu Jiang, Na Wang, Xi Han, Yachun Zhao, Hao Xiong, Xiaofen Liu, Yan Zhao, Chanyue Zhu, Xuejing Sun, Lin DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy |
title | DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy |
title_full | DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy |
title_fullStr | DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy |
title_full_unstemmed | DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy |
title_short | DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy |
title_sort | dsba-l ameliorates renal injury through the ampk/nlrp3 inflammasome signaling pathway in diabetic nephropathy |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120163/ https://www.ncbi.nlm.nih.gov/pubmed/33995126 http://dx.doi.org/10.3389/fphys.2021.659751 |
work_keys_str_mv | AT yangming dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT luoshilu dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT jiangna dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT wangxi dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT hanyachun dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT zhaohao dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT xiongxiaofen dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT liuyan dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT zhaochanyue dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT zhuxuejing dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy AT sunlin dsbalamelioratesrenalinjurythroughtheampknlrp3inflammasomesignalingpathwayindiabeticnephropathy |